Role of the Shu Complex in Homology-directed Chromosome Repair
Shu 复合物在同源定向染色体修复中的作用
基本信息
- 批准号:8447187
- 负责人:
- 金额:$ 5.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-04-01 至 2015-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAlkylating AgentsBindingBiochemicalBiochemical GeneticsBiological ModelsBloom SyndromeCancer BiologyCellsChemicalsChromosomesComplexDNADNA BindingDNA DamageDNA Double Strand BreakDNA RepairDNA Repair PathwayDNA Sequence RearrangementDefectDiseaseDissectionEukaryotaExhibitsFanconi&aposs AnemiaFellowshipFilamentGenerationsGenesGeneticGenetic EpistasisGenomeGenomic InstabilityGenomicsGoalsHereditary Breast CarcinomaHumanHydrolysisIn VitroInvestigationIonizing radiationKnowledgeLifeLightMalignant NeoplasmsMalignant neoplasm of ovaryMediatingMeiosisModelingOrganismOrthologous GenePathway interactionsPhenotypePlayPositioning AttributePredispositionProcessPropertyProteinsRad51 recombinaseRadiationReactionRoleSaccharomyces cerevisiaeSister ChromatidWerner SyndromeWorkassaultcrosslinkhomologous recombinationin vivoinjuredmembermutantnovelpresynapticprotein complexrecombinasereconstitutionrepairedresearch studytelomeretool
项目摘要
DESCRIPTION (provided by applicant): Studies in the model eukaryote Saccharomyces cerevisiae have revealed that homologous recombination (HR) is an important tool for the repair of chromosomes injured by various mutagenic chemicals including alkylating agents and DNA cross-linking agents, and by ionizing radiations that cause DNA double strand breaks. HR also participates in the repair of stalled replication forks and incomplete telomeres. Proteins encoded by evolutionarily conserved genes of the RAD52 epistasis group catalyze the HR reaction. The goal of this project is to elucidate the functional role of the Shu1-Shu2-Csm2-Psy3 (Shu) complex of S. cerevisiae. Several genetic investigations of the Shu complex have revealed that it is an integral component of the RAD52 group, but to date, no mechanistic information is available on the Shu complex. In light of this knowledge gap, we have purified the Shu complex and found that it interacts physically with key components of the HR pathway. Building off of our preliminary findings, the specific aims of this proposal are to: 1) define the biochemical properties of the Shu complex and determine their functional relevance in vivo, and 2) delineate how the Shu complex functions in HR by examining its effects upon the well- understood activities of its interaction partners. These studies seek to shed light on the evolutionarily conserved mechanisms by which the HR pathway maintains genomic integrity. Defects in HR leads to diseases predisposing to cancer in humans, including familial breast and ovarian cancers, Fanconi anemia, Werner's syndrome, and Bloom's syndrome. As such, the results of this work will contribute to a broader understanding of cancer biology.
描述(由申请人提供):酿酒酵母的模型真核生糖酵母中的研究表明,同源重组(HR)是修复由各种诱变化学物质受伤的染色体的重要工具,包括烷基化剂和包括DNA交叉链接剂,以及导致DNA双重链球的离子化辐射剂。人力资源还参加了停滞的复制叉和不完整的端粒的修复。由RAD52上毒组的进化保守基因编码的蛋白质催化HR反应。该项目的目的是阐明S. cerevisiae的Shu1-Shu2-CSM2-PSY3(SHU)复合物的功能作用。 SHU络合物的一些遗传研究表明,它是RAD52组的整体组成部分,但迄今为止,SHU复合物上尚无机械信息。鉴于这种知识差距,我们已经纯化了SHU复合物,并发现它与HR途径的关键组成部分进行了物理相互作用。在我们的初步发现的基础上,该提案的具体目的是:1)定义SHU综合体的生化特性,并确定其在体内的功能相关性,以及2)描述SHU复合物如何通过检查其对其相互作用伙伴的良好理解活动的效果来在HR中发挥作用。这些研究试图阐明HR途径保持基因组完整性的进化保守机制。人力资源缺陷导致疾病易于人类的癌症,包括家族性乳腺癌和卵巢癌,Fanconi贫血,Werner's综合征和Bloom综合征。因此,这项工作的结果将有助于更广泛地了解癌症生物学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM GAINES其他文献
WILLIAM GAINES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM GAINES', 18)}}的其他基金
Role of the Shu Complex in Homology-directed Chromosome Repair
Shu 复合物在同源定向染色体修复中的作用
- 批准号:
8636037 - 财政年份:2012
- 资助金额:
$ 5.22万 - 项目类别:
Role of the Shu Complex in Homology-directed Chromosome Repair
Shu 复合物在同源定向染色体修复中的作用
- 批准号:
8310586 - 财政年份:2012
- 资助金额:
$ 5.22万 - 项目类别:
相似国自然基金
金属/分子筛双功能催化剂的精准调控及其在苯加氢烷基化中的催化研究
- 批准号:22302234
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
ZnCeZrOx@ZSM-5双功能催化剂的构建及催化二氧化碳加氢与苯烷基化性能研究
- 批准号:22309130
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
用于合成气与萘直接烷基化新工艺的双功能催化剂设计合成与构-效关系研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
碳载Pt-酸双功能催化剂的理性构建及其协同催化酮胺还原烷基化性能研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
用于CO2加氢耦合芳烃选择性烷基化高性能催化剂的设计与构筑
- 批准号:22232002
- 批准年份:2022
- 资助金额:280 万元
- 项目类别:重点项目
相似海外基金
Depleting autoantibodies for the treatment of autoimmunity
消耗自身抗体来治疗自身免疫
- 批准号:
10481071 - 财政年份:2022
- 资助金额:
$ 5.22万 - 项目类别:
Depleting autoantibodies for the treatment of autoimmunity
消耗自身抗体来治疗自身免疫
- 批准号:
10698700 - 财政年份:2022
- 资助金额:
$ 5.22万 - 项目类别:
Chromatin-mediated maintenance of genomic integrity in germ cells
染色质介导的生殖细胞基因组完整性的维持
- 批准号:
10291840 - 财政年份:2021
- 资助金额:
$ 5.22万 - 项目类别:
Administrative supplement to support investigation into the structural basis of ubiquitin signaling in response to DNA alkylation damage
支持调查泛素信号传导响应 DNA 烷基化损伤的结构基础的行政补充
- 批准号:
10580459 - 财政年份:2020
- 资助金额:
$ 5.22万 - 项目类别: